Automated longitudinal monitoring of in vivo protein aggregation in neurodegenerative disease C. elegans models
Open Access
- 9 February 2016
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 11 (1) , 1-13
Abstract
While many biological studies can be performed on cell-based systems, the investigation of molecular pathways related to complex human dysfunctions – e.g. neurodegenerative diseases – often requires long-term studies in animal models. The nematode Caenorhabditis elegans represents one of the best model organisms for many of these tests and, therefore, versatile and automated systems for accurate time-resolved analyses on C. elegans are becoming highly desirable tools in the field. We describe a new multi-functional platform for C. elegans analytical research, enabling automated worm isolation and culture, reversible worm immobilization and long-term high-resolution imaging, and this under active control of the main culture parameters, including temperature. We employ our platform for in vivo observation of biomolecules and automated analysis of protein aggregation in a C. elegans model for amyotrophic lateral sclerosis (ALS). Our device allows monitoring the growth rate and development of each worm, at single animal resolution, within a matrix of microfluidic chambers. We demonstrate the progression of individual protein aggregates, i.e. mutated human superoxide dismutase 1 - Yellow Fluorescent Protein (SOD1-YFP) fusion proteins in the body wall muscles, for each worm and over several days. Moreover, by combining reversible worm immobilization and on-chip high-resolution imaging, our method allows precisely localizing the expression of biomolecules within the worms’ tissues, as well as monitoring the evolution of single aggregates over consecutive days at the sub-cellular level. We also show the suitability of our system for protein aggregation monitoring in a C. elegans Huntington disease (HD) model, and demonstrate the system’s ability to study long-term doxycycline treatment-linked modification of protein aggregation profiles in the ALS model. Our microfluidic-based method allows analyzing in vivo the long-term dynamics of protein aggregation phenomena in C. elegans at unprecedented resolution. Pharmacological screenings on neurodegenerative disease C. elegans models may strongly benefit from this method in the near future, because of its full automation and high-throughput potential.Keywords
Funding Information
- European Research Council (ERC-2012-AdG-320404)
- European Research Council (ERC-2008-AdG-23118)
This publication has 53 references indexed in Scilit:
- Mitonuclear protein imbalance as a conserved longevity mechanismNature, 2013
- A microfluidic device for whole-animal drug screening using electrophysiological measures in the nematode C. elegansLab on a Chip, 2012
- The Cell-Non-Autonomous Nature of Electron Transport Chain-Mediated LongevityCell, 2011
- Large-scale in vivo femtosecond laser neurosurgery screen reveals small-molecule enhancer of regenerationProceedings of the National Academy of Sciences, 2010
- A programmable microvalve-based microfluidic array for characterization of neurotoxin-induced responses of individual C. elegansBiomicrofluidics, 2009
- Destabilizing Protein Polymorphisms in the Genetic Background Direct Phenotypic Expression of Mutant SOD1 ToxicityPLOS Genetics, 2009
- Neurons Detect Increases and Decreases in Oxygen Levels Using Distinct Guanylate CyclasesNeuron, 2009
- The Parallel Worm Tracker: A Platform for Measuring Average Speed and Drug-Induced Paralysis in NematodesPLOS ONE, 2008
- Femtosecond laser nanoaxotomy lab-on-a-chip for in vivo nerve regeneration studiesNature Methods, 2008
- C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During AgingPLOS Genetics, 2008